Waters files initial beneficial ownership statement for Steven Conly, SVP of Waters Biosciences
WAT•Waters biosciences SVP Steven Conly reported 6,030 common shares in an initial beneficial ownership statement filed November 6, 2026.
1. Ownership statement
Steven Conly, Waters’ biosciences SVP, reported 6,030 common shares in an initial beneficial ownership statement filed November 6, 2026.
